Thrombotic Microangiopathies Secondary to Anticancer Treatment in Patients Receiving Gemcitabine and Anti-vascular Endothelial Growth Factor: A Case Series
S. Hamine, Z. Shao-Yu, D. Sahali & P. Grimbert · Asian Journal of Research in Nephrology · 2023
Thrombotic microangiopathy (TMA) secondary to anticancer drugs exhibits varying clinicopathological presentation and severity, with variable response and prognosis upon discontinuation of the medication. We conducted a retrospective, monocentric, descriptive, and analytical study...
Open access
Research Article